Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
risedronate sodium, Quantity: 35 mg
Arrotex Pharmaceuticals Pty Ltd
Risedronate sodium
Tablet, film coated
Excipient Ingredients: lactose; macrogol 8000; colloidal anhydrous silica; titanium dioxide; magnesium stearate; hypromellose; iron oxide red; iron oxide yellow; crospovidone; hyprolose
Oral
Pack sizes of 7, 14, 28, 84, 112 tablets per pack
(S4) Prescription Only Medicine
Treatment of osteoporosis.,Treatment of glucocorticoid-induced osteoporosis. ,Preservation of bone mineral density in patients on long term corticosteroid therapy
Visual Identification: Risedronate tablets are orange round biconvex coated tablets engraved APO on one side RIS above 35 on the other side; Container Type: Multiple containers; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-04-13